Medicare announces 15 new drugs up for price negotiations: Read the list

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.

The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, including Ozempic and Wegovy — the blockbuster diabetes and weight loss drugs. The drugs have faced public backlash over their high price, fueling demand for cheaper alternatives.

The list, which includes 15 drugs, up from 10 last year, is the first step in a negotiation process between Medicare and drugmakers that is expected to take place over the coming months. The new negotiated prices won’t take effect until 2027. 

Still, the deliberations — mandated by the Inflation Reduction Act of 2022 — face an uncertain future under the incoming Trump administration, which has remained silent on whether it supports the government program.  

The drugs selected to undergo negotiations are:

Ozempic; Rybelsus; Wegovy, for Type 2 diabetes and weight loss.

https://www.nbcnews.com/health/health-news/medicare-drugs-price-negotiations-ozempic-rcna187937

---